Phase I trial of a micellar nanoparticle cisplatin formulation [Nanoplatin] in patients with solid tumours in Japan

Trial Profile

Phase I trial of a micellar nanoparticle cisplatin formulation [Nanoplatin] in patients with solid tumours in Japan

Recruiting
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2012

At a glance

  • Drugs Cisplatin (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors NanoCarrier
  • Most Recent Events

    • 07 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top